Pneumococcal pneumonia in adults – Re-emergence of vaccine serotypes: a prospective multicentre cohort study in Germany, 2020-2023
De autoria de Christina Bahrs, Norman Rose, Grit Barten-Neiner, Carolin Fleischmann-Struzek, Mark P. G. van der Linden, Gernot Rohde, Jan Rupp, Martin Witzenrath, Jessica Rademacher e Mathias W. Pletz
Publicado
Servidor
medRxiv
DOI
10.1101/2025.10.24.25338303
This prospective multicentre study investigated pneumococcal serotype distribution and vaccine coverage of the 13- and 20-valent conjugate vaccines, and the 23-valent polysaccharide vaccine among adults with community-acquired pneumonia in Germany, from 2020 to 2023, using serotype-specific urine antigen detection testing. The findings show that Streptococcus pneumoniae has reemerged as causative pathogen of pneumonia, particularly in adults aged ≥60 years. This resurgence, observed during the ongoing SARS-CoV-2 pandemic, has been primarily driven by an increase in cases due to serotype 3.
Você pode escrever uma avaliação PREreview de Pneumococcal pneumonia in adults – Re-emergence of vaccine serotypes: a prospective multicentre cohort study in Germany, 2020-2023. Uma avaliação PREreview é uma avaliação de um preprint e pode variar de algumas frases a um parecer extenso, semelhante a um parecer de revisão por pares realizado por periódicos.
Antes de começar
We will ask you to log in with your ORCID iD. If you don’t have an iD, you can create one.
What is an ORCID iD?
An ORCID iD is a unique identifier that distinguishes you from everyone with the same or similar name.